Fumaric Acid

Fumaric Acid

SCHEMBL4244556

COCCNC(=O)c1cc2c(nc(C)n2C)c2c1CCC1(Cc3ccccc3C1)N2.O=C(O)C=CC(=O)O

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A known ✓ Q03164 1/20 0.33
ALDH1A1 P00352 5/20 0.33
WNT3A P56704 1/20 0.33
MAPK1 P28482 1/20 0.32
KDM4E B2RXH2 6/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HPGD P15428 5/20 0.32
ABL1 P00519 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
RIN1 Q13671 1/20 0.32
MAPT P10636 2/20 0.32
GAA P10253 1/20 0.32
PKM P14618 1/20 0.32
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
HSD17B10 Q99714 2/20 0.31
ALOX15 P16050 1/20 0.31
MOK Q9UQ07 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL4244553 1.00 KMT2A (0.33) KMT2AALDH1A1WNT3AMAPK1KDM4E
SCHEMBL4242410 0.95 ALDH1A1 (0.36) KMT2AALDH1A1WNT3AMAPK1KDM4E
Hydrochloric Acid SCHEMBL4245930 0.95 ALDH1A1 (0.35) KMT2AALDH1A1WNT3AMAPK1KDM4E
Malonic Acid SCHEMBL4246390 0.94 ALDH1A1 (0.34) KMT2AALDH1A1WNT3AMAPK1KDM4E
SCHEMBL4243787 0.91 TRPA1 (0.38) KMT2AALDH1A1MAPK1KDM4EHPGD
SCHEMBL4239937 0.87 CDK2 (0.34) KMT2AALDH1A1KDM4EHPGDMAPT
SCHEMBL4241781 0.86 OPRL1 (0.34) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL4235958 0.85 CHIA (0.32) KDM4EHSD17B10
SCHEMBL4241846 0.84 HCN1 (0.30)
SCHEMBL4240859 0.83 CRBN (0.32) ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090093473-A1 Spiro-benzimidazoles as inhibitors of gastric acid secretion NYCOMED GMBH (DE) 2009-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093473-A1 Spiro-benzimidazoles as inhibitors of gastric acid secretion GIPR, PGC, SLC10A2 KMT2A 4175/4885ALDH1A1 187/4885WNT3A 3122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.